1159 related articles for article (PubMed ID: 12414634)
81. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells.
Price MA; Case SS; Carbonaro DA; Yu XJ; Petersen D; Sabo KM; Curran MA; Engel BC; Margarian H; Abkowitz JL; Nolan GP; Kohn DB; Crooks GM
Mol Ther; 2002 Nov; 6(5):645-52. PubMed ID: 12409263
[TBL] [Abstract][Full Text] [Related]
82. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
83. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints.
Rouas R; Uch R; Cleuter Y; Jordier F; Bagnis C; Mannoni P; Lewalle P; Martiat P; Van den Broeke A
Cancer Gene Ther; 2002 Sep; 9(9):715-24. PubMed ID: 12189521
[TBL] [Abstract][Full Text] [Related]
84. [Construction of bicistronic lentiviral vectors carrying HSV-tk and EGFP gene].
Yang J; Lu Y; Guo LH; Liu TJ; Mo XF
Zhonghua Yan Ke Za Zhi; 2007 May; 43(5):387-92. PubMed ID: 17706084
[TBL] [Abstract][Full Text] [Related]
85. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
[TBL] [Abstract][Full Text] [Related]
86. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap.
Dardalhon V; Herpers B; Noraz N; Pflumio F; Guetard D; Leveau C; Dubart-Kupperschmitt A; Charneau P; Taylor N
Gene Ther; 2001 Feb; 8(3):190-8. PubMed ID: 11313790
[TBL] [Abstract][Full Text] [Related]
87. Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons.
Horn PA; Morris JC; Bukovsky AA; Andrews RG; Naldini L; Kurre P; Kiem HP
Gene Ther; 2002 Nov; 9(21):1464-71. PubMed ID: 12378409
[TBL] [Abstract][Full Text] [Related]
88. A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer.
Tait DL; Obermiller PS; Redlin-Frazier S; Jensen RA; Welcsh P; Dann J; King MC; Johnson DH; Holt JT
Clin Cancer Res; 1997 Nov; 3(11):1959-68. PubMed ID: 9815585
[TBL] [Abstract][Full Text] [Related]
89. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice.
Jorgensen C; Demoly P; Noel D; Mathieu M; Piechaczyc M; Gougat C; Bousquet J; Sany J
J Rheumatol; 1997 Nov; 24(11):2076-9. PubMed ID: 9375863
[TBL] [Abstract][Full Text] [Related]
90. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector.
Dolivet G; Merlin JL; Barberi-Heyob M; Ramacci C; Erbacher P; Parache RM; Behr JP; Guillemin F
Cancer Gene Ther; 2002 Aug; 9(8):708-14. PubMed ID: 12136433
[TBL] [Abstract][Full Text] [Related]
91. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
[TBL] [Abstract][Full Text] [Related]
92. Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene.
Puig T; Kádár E; Limón A; Cancelas JA; Eixarch H; Luquín L; García M; Barquinero J
Gene Ther; 2002 Nov; 9(21):1472-9. PubMed ID: 12378410
[TBL] [Abstract][Full Text] [Related]
93. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair.
Mason JM; Grande DA; Barcia M; Grant R; Pergolizzi RG; Breitbart AS
Gene Ther; 1998 Aug; 5(8):1098-104. PubMed ID: 10326033
[TBL] [Abstract][Full Text] [Related]
94. In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.
Gadi VK; Alexander SD; Kudlow JE; Allan P; Parker WB; Sorscher EJ
Gene Ther; 2000 Oct; 7(20):1738-43. PubMed ID: 11083495
[TBL] [Abstract][Full Text] [Related]
95. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT
Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401
[TBL] [Abstract][Full Text] [Related]
96. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
Furler S; Paterna JC; Weibel M; Büeler H
Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
[TBL] [Abstract][Full Text] [Related]
97. Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro.
Kelly FJ; Miller CR; Buchsbaum DJ; Gomez-Navarro J; Barnes MN; Alvarez RD; Curiel DT
Clin Cancer Res; 2000 Nov; 6(11):4323-33. PubMed ID: 11106250
[TBL] [Abstract][Full Text] [Related]
98. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
99. Stable transgene expression in tumors and metastases after transduction with lentiviral vectors based on human immunodeficiency virus type 1.
Bao L; Jaligam V; Zhang XY; Kutner RH; Kantrow SP; Reiser J
Hum Gene Ther; 2004 May; 15(5):445-56. PubMed ID: 15144575
[TBL] [Abstract][Full Text] [Related]
100. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Shiau AL; Lin CY; Tzai TS; Wu CL
Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
